About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Managing Appropriate Prescribing in COPD | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT04539457

Managing Appropriate Prescribing in COPD

Objective: Reducing inappropriate medications for primary care COPD patients with comorbidities ('medication-comorbidity clashes'), by evaluation of the Desktop Helper (number 10) in a pragmatic clust...

Lead sponsor: General Practitioners Research Institute•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

General Practitioners Research Institute

Collaborators

Boehringer Ingelheim

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Primary care patients with COPD aged 18 years and older with one or more (co)morbidities.
•A clinical GP diagnosis of COPD (ICPC code R95 (emphysema/COPD).
•Presence of one or more of the following (co)morbidities: Glaucoma (ICPC code F93\*), Kidney failure / renal insufficiency (ICPC code: U99.01), Tuberculosis (ICPC code: A70, R70), Diabetes (ICPC code: T90, A91.05), Pneumonia (ICPC code: R81, R81.01), Osteoporosis/osteopenia (ICPC code: L95, L95.02, L95.01), Prostate symptoms (ICPC code: Y06, U05.02), Atrium fibrillation (ICPC code: K78, K79, K80, K84.02, K04, K05), Bronchiectasis (ICPC code: R91, R91.02) and Asthma (ICPC code: R96, R96.02)

Exclusion Criteria

•Have end-stage COPD or a life expectancy \< 6 months
•If they underwent a systematic medication review aimed at reducing inappropriate prescribing. Systematic refers to a collaboration with a pharmacist and the adoption of Beers, STOPP and or START criteria.

Related studies

Pulmonary Rehabilitation for Rural Patients With COPD

NCT06847061 · Chronic Obstructive Pulmonary Disease (COPD

Study of Patient With Frequent Exacerbations in Moscow

NCT07307781 · Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease and Asthma in Workers at Navanakorn Industrial Zone, Thailand

NCT07383896 · Asthma, COPD

Exploring Multimorbidity in Patients With Spinal Pain

NCT06402409 · Back Pain, Neck Pain, and more

Using Multiomics to Define Mechanisms of Rhinovirus-induced Chronic Obstructive Pulmonary Disease Exacerbations to Develop Novel Therapies and Therapeutic Targets

NCT07112235 · COPD (Chronic Obstructive Pulmonary Disease), Rhinovirus Infection, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 24, 2023Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment24

Start dateJun 2021

Last updatedFeb 24, 2023

Condition

COPD Comorbidities and Coexisting Conditions

Locations shown

General Practitioners Research Institute

Groningen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 24, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions